Risk factors differentiating mild/moderate from severe meconium aspiration syndrome in meconium-stained neonates.
- Author:
Woneui CHOI
1
;
Heejeong JEONG
;
Suk Joo CHOI
;
Soo Young OH
;
Jung Sun KIM
;
Cheong Rae ROH
;
Jong Hwa KIM
Author Information
- Publication Type:Original Article
- Keywords: Meconium aspiration syndrome; Risk factors
- MeSH: Female; Fever; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Infant, Newborn*; Meconium; Meconium Aspiration Syndrome*; Parity; Parturition; Risk Factors*; Tachycardia; Trial of Labor
- From:Obstetrics & Gynecology Science 2015;58(1):24-31
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: The aim of this study was to compare the risk factors associated with mild/moderate meconium aspiration syndrome (MAS) with those associated with severe in meconium-stained term neonates. METHODS: Consecutive singleton term neonates (n=671) with meconium staining at birth from all deliveries (n=14,666) in our institution from January 2006 to December 2012 were included. Both maternal and neonatal variables were examined. Among the study population, for women who underwent the trial of labor (n=644), variables associated with labor were also examined. These variables were compared between the mild/moderate MAS group, the severe MAS group, and the MAS-absent group. RESULTS: MAS developed in 10.6% (71/671) of neonates with meconium staining at birth. Among the neonates with MAS, 81.7% had mild MAS, 5.6% had moderate MAS, and 12.7% had severe MAS. The presence of minimal variability was significantly increased in both the mild/moderate and the severe MAS groups. The frequencies of nulliparity, fetal tachycardia, and intrapartum fever were significantly increased in the mild/moderate MAS group, but not in the severe MAS group. While a longer duration of the second stage of labor was significantly associated with mild/moderate MAS, severe MAS was associated with a shorter duration of the second stage. Notably, low mean cord pH (7.165 [6.850-7.375]) was significantly associated with mild/moderate MAS, but not with severe MAS (7.220 [7.021-7.407]) compared with the absence of MAS (7.268 [7.265-7.271]). CONCLUSION: Our data suggest the development of severe MAS is not simply a linear extension of the same risk factors driving mild/moderate MAS.
